Interaction of drug metabolism with the other elements of drug safety evaluation.
D000818:Animals; D002522:Chlorocebus aethiops; D003493:Cyclacillin / Q000009:adverse effects / Q000378:metabolism; D003515:Cycloleucine / Q000378:metabolism; D004285:Dogs; D064420:Drug-Related Side Effects and Adverse Reactions; D004967:Estrogens / Q000096:biosynthesis; D005260:Female; D006207:Half-Life; D000882:Haplorhini; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008253:Macaca mulatta; D008297:Male; D009644:Norgestrel / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013552:Swine
D004967:Estrogens; D004364:Pharmaceutical Preparations; D003515:Cycloleucine; D009644:Norgestrel; D003493:Cyclacillin